Compare UNB & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNB | STXS |
|---|---|---|
| Founded | 1891 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.6M | 139.3M |
| IPO Year | 1999 | 2004 |
| Metric | UNB | STXS |
|---|---|---|
| Price | $22.89 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 2.3K | ★ 521.9K |
| Earning Date | 11-09-2026 | 08-11-2026 |
| Dividend Yield | ★ 6.26% | N/A |
| EPS Growth | ★ 25.52 | 16.67 |
| EPS | ★ 1.25 | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | N/A | $6.04 |
| Revenue Next Year | N/A | $33.01 |
| P/E Ratio | $18.40 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.65 | $1.00 |
| 52 Week High | $26.41 | $3.15 |
| Indicator | UNB | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 21.13 |
| Support Level | $22.91 | N/A |
| Resistance Level | $24.16 | $1.97 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 19.02 | 13.31 |
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.